CalciMedica (CALC) Net Cash Flow (2019 - 2026)
CalciMedica's (CALC) quarterly Net Cash Flow came in at -$3.4 million in Q1 2026, down 172.62% YoY from $4.6 million in Q1 2025, and down 155.47% on a QoQ basis from $6.0 million in Q4 2025.
CalciMedica (CALC) Net Cash Flow (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Net Cash Flow data on file, last reported at -$3.4 million in Q1 2026.
- Quarterly Net Cash Flow fell 172.62% year-over-year to -$3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 175.71% YoY) and the FY2025 annual result came in at $3.6 million, up 49.06% from the prior year.
- Net Cash Flow retreated to -$3.4 million in Q1 2026, from $6.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $22.9 million in Q1 2023 to a low of -$7.4 million in Q3 2023.
- A 5-year average of $200176.5 and a median of -$910000.0 in 2022 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 731.3% in 2023, down 5804.76% in 2023.
- Tracing CALC's Net Cash Flow over 5 years: stood at $1.4 million in 2022, then slumped by 543.04% to -$6.1 million in 2023, then surged by 80.09% to -$1.2 million in 2024, then jumped by 597.12% to $6.0 million in 2025, then sank by 155.47% to -$3.4 million in 2026.
- The last three Net Cash Flow figures came in at -$3.4 million (Q1 2026), $6.0 million (Q4 2025), and -$448000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -496,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.14 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | 10.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.45 Mn |
| Jun 30, 2026 | 10.45 Mn |
| Mar 31, 2026 | -3.36 Mn |
| Mar 31, 2026 | -3.36 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | -448,000.00 |
| Sep 30, 2025 | -448,000.00 |
| Jun 30, 2025 | -6.64 Mn |
| Jun 30, 2025 | -6.64 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Mar 31, 2025 | 4.62 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |